Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study-Reference-Cited by-同舟云学术

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

Published:2015-04 Issue:4 Volume:2 Page:e127-e136
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Molina Jean-Michel,Clotet Bonaventura,van Lunzen Jan,Lazzarin Adriano,Cavassini Matthias,Henry Keith,Kulagin Valeriv,Givens Naomi,de Oliveira Carlos Fernando,Brennan Clare

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference26 articles.

1. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society−USA panel;Günthard;JAMA,2014

2. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1;Daar;Ann Intern Med,2011

3. Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks;Aberg;AIDS Res Hum Retroviruses,2012

4. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial;Lennox;Ann Intern Med,2014

5. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study;Biomedicines;2024-09-12

2. Cost-effectiveness of pretreatment HIV drug resistance testing in people living with HIV in Iran;PLOS ONE;2024-09-06

3. Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review;Infectious Disease Reports;2024-09-01

4. Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era;Journal of Biomedical Science;2024-08-19

5. Factors Associated with Time to Initial Antiretroviral Therapy Discontinuation in the DC Cohort;AIDS Research and Human Retroviruses;2024-07-23